Senegal is pioneering the use of an anti-malarial, chloroquine, to treat coronavirus patients and the result is impressive the government says.
The WHO says its effectiveness has not been established, and other medical institutions have warned against the hype surrounding the drug.
But Senegal
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
